IgAN
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. In line with Western medicine IgA nephropathy and renal function in line with the diagnostic criteria of CKD stage 1-4; 2. It conforms to the diagnostic criteria of TCM syndrome differentiation; 3. Patients are between 18 and 75 years of age, regardless of gender; 4. Infection, acidosis, electrolyte disturbance and hypertension have been well controlled; 5. No other organ function failure; 6. Have good compliance, have not participated in other clinical trials in recent half a year; 7. Informed and willing to accept clinical investigators.
Exclusion criteria
Exclusion criteria: 1. People who are allergic or allergic to known ingredients of the study drug; 2. Patients diagnosed with acute renal failure, and patients undergoing hemodialysis or peritoneal dialysis; 3. Patients with serious damage to the heart, liver, lung and other organs, or patients with wasting diseases such as malignant tumor or active tuberculosis; 4. Patients with gastrointestinal bleeding, or need to take other types of Chinese medicine during the test; 5. Those who do not cooperate with treatment; 6. Recent history of surgery; 7. Pregnant and lactating women; 8. Participants considered inappropriate by the investigator to participate in clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 24-hour urinary protein quantity;ACE II;AOPPs;Glutathione peroxidase;MDA;ACE2;Ang(1-7);Anti-NADPH oxidase 4;ACE; | — |
Countries
China
Contacts
Zhejiang Provincal Hospital of traditional Chinese medicine